Lentiviral vector-induced SmartDC-TRP2 for melanoma immunotherapy: immunemonitoring validation assays and GMP development (2012)

First Author: Stripecke R.
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 23

Parent Publication: HUMAN GENE THERAPY

Issue: 10

ISSN: 1043-0342